87 related articles for article (PubMed ID: 21866658)
1. [Effect of danshen chuanxiongqin injection on the myocardial damage of unstable angina patients undergoing percutaneous coronary intervention].
Wang R; Han QH; Jia YP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jul; 31(7):899-902. PubMed ID: 21866658
[TBL] [Abstract][Full Text] [Related]
2. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
[TBL] [Abstract][Full Text] [Related]
3. [Preventive Effect of Fangshuan Capsule on PCI-induced Myocardial Damage and Vascular Endo- thelial Injury in Patients with Unstable Angina Pectoris].
Wang ZL; Zhang PY; Liu M; Liang T; Zhang HM; Mel FG; Zhao G; Li JL; Chen LX; Cui WD; Zhang Q; Lu L; Fan QL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Nov; 36(11):1295-1299. PubMed ID: 30641618
[TBL] [Abstract][Full Text] [Related]
4. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
6. Effects of Danhong Injection () on Peri-Procedural Myocardial Injury and Microcirculatory Resistance in Patients with Unstable Angina Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study.
Xing WL; Wu YJ; Liu HX; Liu QR; Zhou Q; Li AY; Zhang ZH; Li X
Chin J Integr Med; 2021 Nov; 27(11):846-853. PubMed ID: 34263442
[TBL] [Abstract][Full Text] [Related]
7. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
Sun F; Yin Z; Shi Q; Zhao B; Wang S
Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
[TBL] [Abstract][Full Text] [Related]
8. Final myocardial blush grade predicts troponin I elevation in unstable angina patients undergoing percutaneous intervention.
Prasan AM; Flood C; Pitney MR; Walsh W; Jepson NS
Heart Lung Circ; 2006 Oct; 15(5):291-6. PubMed ID: 16860603
[TBL] [Abstract][Full Text] [Related]
9. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
10. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
[TBL] [Abstract][Full Text] [Related]
11. Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
Foroughinia F; Salamzadeh J; Namazi MH
Cardiovasc Ther; 2013 Oct; 31(5):268-73. PubMed ID: 23134549
[TBL] [Abstract][Full Text] [Related]
12. [Myocardial protective effect of Danhong Injection evaluated by velocity vector imaging in patients undergoing percutaneous coronary intervention].
Dong J; Chen Y; Zhi G; Liu H; Wang J; Tian F; Zhou Y; Chen J
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(30):2346-9. PubMed ID: 25399975
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of cardiac troponin I in patients with acute myocardial infarction and unstable angina.
Selim NA; Hmouda HT
Saudi Med J; 2002 May; 23(5):526-8. PubMed ID: 12070573
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
[TBL] [Abstract][Full Text] [Related]
15. [Changes of serum hepatocyte growth factor before and after percutaneous coronary intervention in patients with unstable angina pectoris and significance there].
Wang NF; Tong GX; Li PZ; Zhang XW; Xu J; Wu GP; Jin JF; Zhou L; Ye XH; Yang JM; Pan H
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1411-3. PubMed ID: 17785064
[TBL] [Abstract][Full Text] [Related]
16. [Effect of tetramethylpyrazine on platelet activation and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention].
Chen ZQ; Hong L; Wang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1078-81. PubMed ID: 18198639
[TBL] [Abstract][Full Text] [Related]
17. [Effects of preconditioning and postconditioning on emergency percutaneous coronary intervention in patients with acute myocardial infarction].
Ma XJ; Zhang XH; Luo M; Li CM; Shao JH
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):114-7. PubMed ID: 17418019
[TBL] [Abstract][Full Text] [Related]
18. Use of thrombolysis in myocardial infarction risk score to predict bleeding complications in patients with unstable angina and non-ST elevation myocardial infarction undergoing percutaneous coronary intervention.
Numasawa Y; Kohsaka S; Miyata H; Kawamura A; Noma S; Suzuki M; Nakagawa S; Momiyama Y; Takahashi T; Sato Y; Fukuda K
Cardiovasc Interv Ther; 2013 Jul; 28(3):242-9. PubMed ID: 23361950
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
20. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
Pelliccia F; Pasceri V; Marazzi G; Rosano G; Greco C; Gaudio C
Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
